Log in
NASDAQ:GHSI

Guardion Health Sciences Stock Forecast, Price & News

$0.29
+0.03 (+11.37 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.27
Now: $0.29
$0.32
50-Day Range
$0.17
MA: $0.20
$0.26
52-Week Range
$0.17
Now: $0.29
$0.74
Volume16.12 million shs
Average Volume7.13 million shs
Market Capitalization$25.95 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.08
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Medical Devices. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Medical Devices segment offers VectorVision, which develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing; CSV-1000, an instrument for contrast sensitivity, glare sensitivity, low contrast acuity, and early treatment diabetic retinopathy; CSV-2000, a digital standardized contrast sensitivity testing device; and MapcatSF, a medical device that measures the macular pigment optical density. The company distributes its products through sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GHSI
CUSIPN/A
CIKN/A
Phone858-605-9055
Employees21

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$900,000.00
Book Value$0.12 per share

Profitability

Net Income$-10,880,000.00
Net Margins-480.23%

Miscellaneous

Market Cap$25.95 million
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
$0.29
+0.03 (+11.37 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GHSI News and Ratings via Email

Sign-up to receive the latest news and ratings for GHSI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Guardion Health Sciences (NASDAQ:GHSI) Frequently Asked Questions

How has Guardion Health Sciences' stock been impacted by Coronavirus (COVID-19)?

Guardion Health Sciences' stock was trading at $0.39 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GHSI shares have decreased by 24.7% and is now trading at $0.2938.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Guardion Health Sciences?

Wall Street analysts have given Guardion Health Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Guardion Health Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Guardion Health Sciences' next earnings date?

Guardion Health Sciences is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Guardion Health Sciences
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) posted its quarterly earnings data on Thursday, November, 12th. The company reported ($0.02) EPS for the quarter. The company had revenue of $0.25 million for the quarter. Guardion Health Sciences had a negative net margin of 480.23% and a negative return on equity of 75.36%.
View Guardion Health Sciences' earnings history
.

Are investors shorting Guardion Health Sciences?

Guardion Health Sciences saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 368,400 shares, a decline of 32.1% from the October 31st total of 542,700 shares. Based on an average daily trading volume, of 3,800,000 shares, the days-to-cover ratio is currently 0.1 days.
View Guardion Health Sciences' Short Interest
.

Who are some of Guardion Health Sciences' key competitors?

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).

Who are Guardion Health Sciences' key executives?

Guardion Health Sciences' management team includes the following people:
  • Mr. Robert Neal Weingarten, Independent Chairman & Sec. (Age 68, Pay $60k)
  • Dr. David W. Evans, Interim Pres, Interim CEO, Chief Scientific Officer & Director (Age 64)
  • Mr. Andrew C. Schmidt, VP & CFO (Age 59)

When did Guardion Health Sciences IPO?

(GHSI) raised $6 million in an initial public offering on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

What is Guardion Health Sciences' stock symbol?

Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI."

Who are Guardion Health Sciences' major shareholders?

Guardion Health Sciences' stock is owned by many different retail and institutional investors. Top institutional shareholders include Cambridge Investment Research Advisors Inc. (0.29%).

Which major investors are buying Guardion Health Sciences stock?

GHSI stock was purchased by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc..

How do I buy shares of Guardion Health Sciences?

Shares of GHSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Guardion Health Sciences' stock price today?

One share of GHSI stock can currently be purchased for approximately $0.29.

How big of a company is Guardion Health Sciences?

Guardion Health Sciences has a market capitalization of $25.95 million and generates $900,000.00 in revenue each year. Guardion Health Sciences employs 21 workers across the globe.

What is Guardion Health Sciences' official website?

The official website for Guardion Health Sciences is www.guardionhealth.com.

How can I contact Guardion Health Sciences?

Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The company can be reached via phone at 858-605-9055 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.